Sunil Badve
Badve, Sunil, 19..-....
Badve, Sunil
VIAF ID: 782167445362488860003 (Personal)
Permalink: http://viaf.org/viaf/782167445362488860003
Preferred Forms
-
- 100 1 _ ‡a Badve, Sunil, ‡d 19..-....
- 100 0 _ ‡a Sunil Badve
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Acute renal tubular injury with acute hepatitis A infection: is it just a coincidence? | |
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. | |
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. | |
APPETITE PREDICTS INTAKE AND NUTRITIONAL STATUS IN PATIENTS RECEIVING PERITONEAL DIALYSIS. | |
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca | |
The association between body mass index and mortality in incident dialysis patients | |
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | |
Biocompatible dialysis fluids for peritoneal dialysis | |
Challenges of conducting a trial of uric-acid-lowering therapy in CKD. | |
Chronic kidney disease: haemodialysis catheter care in practice. | |
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis | |
Daily home hemodialysis: balancing cardiovascular benefits with infectious harms. | |
Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis | |
Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies | |
Does Sevelamer reduce mortality by slowing of progression of coronary calcification? | |
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial | |
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial | |
The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. | |
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis | |
End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. | |
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network | |
Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials | |
The HONEYPOT randomized controlled trial statistical analysis plan | |
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients | |
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease | |
Invasion in breast lesions: the role of the epithelial-stroma barrier. | |
Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD? | |
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry | |
Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - a population cohort study | |
Long-term outcomes of end-stage kidney disease for patients with lupus nephritis | |
Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients. | |
Molecular pathology of breast cancer, 2016: | |
Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis | |
A nephrology guide to reading and using systematic reviews of randomized trials | |
The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. | |
Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. | |
Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics. | |
Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk | |
Phyllodes tumours of the breast: a consensus review | |
Predictive biomarkers in oncology : applications in precision medicine | |
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). | |
A Randomized Controlled Trial of Intravenous or Oral Iron for Posttransplant Anemia in Kidney Transplantation | |
The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study | |
Recent evidence for direct oral anticoagulants in chronic kidney disease | |
The Relationship Between Body Mass Index and Organism-Specific Peritonitis | |
REPRESENTATIVENESS OF HONEYPOT TRIAL PARTICIPANTS TO AUSTRALASIAN PD PATIENTS. | |
Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study. | |
Socio-Economic Status and Peritonitis in Australian Non-Indigenous Peritoneal Dialysis Patients. | |
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. | |
Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study | |
Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet? | |
Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function | |
The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis | |
Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis. |